- Home
- OLMA vs SPOK Comparison
OLMA vs SPOK Comparison
Compare OLMA & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- SPOK
- Stock Information
- Founded
- OLMA 2006
- SPOK 2004
- Country
- OLMA United States
- SPOK United States
- Employees
- OLMA N/A
- SPOK N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- SPOK Telecommunications Equipment
- Sector
- OLMA Health Care
- SPOK Telecommunications
- Exchange
- OLMA Nasdaq
- SPOK Nasdaq
- Market Cap
- OLMA 378.9M
- SPOK 379.1M
- IPO Year
- OLMA 2020
- SPOK 1992
- Fundamental
- Price
- OLMA $7.89
- SPOK $17.35
- Analyst Decision
- OLMA Strong Buy
- SPOK Hold
- Analyst Count
- OLMA 5
- SPOK 1
- Target Price
- OLMA $24.00
- SPOK $15.00
- AVG Volume (30 Days)
- OLMA 1.0M
- SPOK 115.4K
- Earning Date
- OLMA 11-11-2025
- SPOK 10-29-2025
- Dividend Yield
- OLMA N/A
- SPOK 7.16%
- EPS Growth
- OLMA N/A
- SPOK 10.71
- EPS
- OLMA N/A
- SPOK 0.83
- Revenue
- OLMA N/A
- SPOK $140,742,000.00
- Revenue This Year
- OLMA N/A
- SPOK $2.26
- Revenue Next Year
- OLMA N/A
- SPOK $3.69
- P/E Ratio
- OLMA N/A
- SPOK $21.04
- Revenue Growth
- OLMA N/A
- SPOK 1.79
- 52 Week Low
- OLMA $2.86
- SPOK $13.55
- 52 Week High
- OLMA $13.93
- SPOK $19.31
- Technical
- Relative Strength Index (RSI)
- OLMA 66.97
- SPOK 51.15
- Support Level
- OLMA $7.49
- SPOK N/A
- Resistance Level
- OLMA $8.25
- SPOK $17.70
- Average True Range (ATR)
- OLMA 0.66
- SPOK 0.34
- MACD
- OLMA 0.12
- SPOK -0.70
- Stochastic Oscillator
- OLMA 80.06
- SPOK 95.02
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.